Raphael Mohr

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 18

Top Topics

Finite Element Analysis

Liver Metastases

Radiofrequency Ablation

Top Venues

International journal of molecular sciences

Alimentary pharmacology & therapeutics

Communications biology

This page only lists publications with an associated author ORCID identifier.

Publications

Can Kamali, Philipp Brunnbauer, Kaan Kamali, Al-Hussein Ahmed Saqr, Alexander Arnold, Gülçin Harman Kamalı, Julia Babigian, Eriselda Keshi, Raphael Mohr, Matthäus Felsenstein, Simon Moosburner, Karl-Herbert Hillebrandt, Jasmin Bartels, Igor Maximillian Sauer, Frank Tacke, Moritz Schmelzle, Johann Pratschke, Felix Krenzien
Extracellular NAD + response to post-hepatectomy liver failure: bridging preclinical and clinical findings. Communications biology 7 (1) (2024)
Raphael Mohr, Frank Tacke, Christoph Roderburg
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' reply. Alimentary pharmacology & therapeutics 59 (11) (2024)
Can Kamali, Philipp Brunnbauer, Kaan Kamali, Al-Hussein Ahmed Saqr, Alexander Arnold, Gülçin Harman Kamalı, Julia Babigian, Eriselda Keshi, Raphael Mohr, Matthäus Felsenstein, Simon Moosburner, Karl-Herbert Hillebrandt, Jasmin Bartels, Igor Maximillian Sauer, Frank Tacke, Moritz Schmelzle, Johann Pratschke, Felix Krenzien
Extracellular NAD + response to post-hepatectomy liver failure: bridging preclinical and clinical findings. Communications biology 7 (1) (2024)
Can Kamali, Philipp Brunnbauer, Kaan Kamali, Al-Hussein Ahmed Saqr, Alexander Arnold, Gülçin Harman Kamalı, Julia Babigian, Eriselda Keshi, Raphael Mohr, Matthäus Felsenstein, Simon Moosburner, Karl-Herbert Hillebrandt, Jasmin Bartels, Igor Maximillian Sauer, Frank Tacke, Moritz Schmelzle, Johann Pratschke, Felix Krenzien
Extracellular NAD + response to post-hepatectomy liver failure: bridging preclinical and clinical findings. Communications biology 7 (1) (2024)
Raphael Mohr, Frank Tacke, Christoph Roderburg
Letter: Presence of progression or absence of response? Alternative trial designs for immunotherapy of advanced hepatocellular carcinoma. Authors' reply. Alimentary pharmacology & therapeutics 59 (11) (2024)
Timo Alexander Auer, Federico Collettini, Laura Segger, Uwe Pelzer, Raphael Mohr, Felix Krenzien, Bernhard Gebauer, Dominik Geisel, Clarissa Hosse, Wenzel Schöning, Fehrenbach Uli
Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma. Cancers 15 (9) (2023)
Alena Laschtowitz, Joeri Lambrecht, Tobias Puengel, Frank Tacke, Raphael Mohr
Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression. International journal of molecular sciences 24 (6) (2023)
Leonie Müller-Jensen, Axel Ronald Schulz, Henrik E Mei, Raphael Mohr, Claas Ulrich, Philipp Knape, Nikolaj Frost, Stefan Frischbutter, Désirée Kunkel, Christian Schinke, Lorena Ginesta Roque, Smilla K Maierhof, Florian T Nickel, Lucie Heinzerling, Matthias Endres, Wolfgang Boehmerle, Petra Huehnchen, Samuel Knauss
Immune signatures of checkpoint inhibitor-induced autoimmunity - a focus on neurotoxicity. Neuro-oncology (2023)
Johannes Eschrich, Zuzanna Kobus, Dominik Geisel, Sebastian Halskov, Florian Rossner, Christoph Roderburg, Raphael Mohr, Frank Tacke
The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma-State of the Art and Future Perspectives. Cancers 15 (1) (2023)
Johannes Eschrich, Zuzanna Kobus, Dominik Geisel, Sebastian Halskov, Florian Rossner, Christoph Roderburg, Raphael Mohr, Frank Tacke
The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma-State of the Art and Future Perspectives. Cancers 15 (1) (2023)
Timo Alexander Auer, Federico Collettini, Laura Segger, Uwe Pelzer, Raphael Mohr, Felix Krenzien, Bernhard Gebauer, Dominik Geisel, Clarissa Hosse, Wenzel Schöning, Fehrenbach Uli
Interventional Treatment Strategies in Intrahepatic Cholangiocarcinoma and Perspectives for Combined Hepatocellular-Cholangiocarcinoma. Cancers 15 (9) (2023)
Alena Laschtowitz, Joeri Lambrecht, Tobias Puengel, Frank Tacke, Raphael Mohr
Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression. International journal of molecular sciences 24 (6) (2023)
Johannes Eschrich, Zuzanna Kobus, Dominik Geisel, Sebastian Halskov, Florian Rossner, Christoph Roderburg, Raphael Mohr, Frank Tacke
The Diagnostic Approach towards Combined Hepatocellular-Cholangiocarcinoma-State of the Art and Future Perspectives. Cancers 15 (1) (2023)
Alena Laschtowitz, Joeri Lambrecht, Tobias Puengel, Frank Tacke, Raphael Mohr
Serum CXCL5 Detects Early Hepatocellular Carcinoma and Indicates Tumor Progression. International journal of molecular sciences 24 (6) (2023)
Fabian Jost-Brinkmann, Münevver Demir, Alexander Wree, Tom Luedde, Sven H Loosen, Tobias Mueller, Frank Tacke, Christoph Roderburg, Raphael Mohr
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: Results from a German real-world cohort. Alimentary pharmacology & therapeutics (2023)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)
Friedrich Sinner, Matthias Pinter, Bernhard Scheiner, Thomas Jens Ettrich, Niklas Sturm, Maria Angeles Gonzalez-Carmona, Oliver Waidmann, Fabian Finkelmeier, Vera Himmelsbach, Enrico N De Toni, Najib Ben Khaled, Raphael Mohr, Thorben Wilhelm Fründt, Fabian Kütting, Florian van Boemmel, Sabine Lieb, Sebastian Krug, Dominic Bettinger, Michael Schultheiß, Leonie S Jochheim, Jan Best, Christian Müller, Verena Keitel, Marino Venerito
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience. Cancers 14 (23) (2022)